Frequency and response to vaginal symptoms among white and African American women: Results of a random digit dialing survey

Journal of Women's Health

Volumn 7, Issue 9, 1998, Pages 1167-1174

  Foxman, Betsy ^a,c   Marsh, Jane V ^a   Gillespie, Brenda ^a   Sobel, Jack D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wayne State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NON PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CAUCASIAN; CONSULTATION; CONTROLLED STUDY; EDUCATION; EMPLOYMENT; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MARRIAGE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SYMPTOM; TELEPHONE; UNITED STATES; VAGINA DISEASE;

EID: 0032406959     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.1167     Document Type: Article

References (14)

1. Schappert SM. National ambulatory medical care survey, 1991 summary. National Center for Health Statistics. Vital Health Statistics 1994;13:59.
2. Stock Checker. Feminine health care: A changing market share. Drug Topics 1996;42.
3. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996;42:595.
4. Sobel JD, Vazquez JA. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin Infect Dis 1996;22:726.
5. Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: Implications for patient care. J Clin Pharmacol 1992;32:248.
6. Taylor CA, Lispky MS. Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents. J Fam Pract 1994;38:157.
7. SAS Institute Inc. SAS language guide for personal computers, Version 6 ed. Gary, NC: SAS Institute Inc., 1985.
8. Geiger AM, Foxman B, Gillespie BW. Epidemiology of vulvovaginal candidiasis among university students. Am J Public Health 1995;85:1146.
9. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: A case-control study among university students. Epidemiology 1996;7:182.
10. Aral SO, Mosher WD, Cates W. Vaginal douching among women of reproductive age in the United States: 1988. Am J Public Health 1992;82:210.
11. Foxman B, Aral SO, Holmes KK. Heterosexual repertoire is associated with same-sex experience. J Sex Trans Dis 1998;25:232.
12. Hellberg D, Zdolsek B, Nilsson S, Mardh PA. Sexual behavior of women with repeated episodes of vulvovaginal candidiasis. Eur J Epidemiol 1995;11:575.
13. Ericksen KP, Trocki KF. Sex, alcohol and sexually transmitted diseases: A national survey. Fam Plan Perspect 1994;26:257.
14. Gannon K. Rx-to-OTC switches fuel growth of yeast infection category. Drug Topics 1991;135:49.